Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
The Journal of Invasive Cardiology|April 4, 2000
Readministration of abciximab in percutaneous coronary interventionE T FryClinical Cardiology|April 5, 2001
Glycoprotein IIb/IIIa inhibitors and low-molecular-weight heparins: a combined role in coronary interventions?E T FryBlood|May 1, 1988
Lack of interference by heparin with thrombolysis or binding of tissue-type plasminogen activator to thrombiE T Fry, B E SobelThrombosis and Haemostasis|November 24, 1989
The nature of synergy between tissue-type and single chain urokinase-type plasminogen activatorsE T Fry, D L Mack, B E SobelCurrent Opinion in Cardiology|March 26, 1999
New intracoronary stent designs: form follows function versus function follows formE T Fry, J B Hermiller, C A PinkertonCirculation|April 1, 1988
Biochemical determinants of clearance of tissue-type plasminogen activator from the circulationC L Lucore, E T Fry, D A Nachowiak, et al.Clinical Cardiology|June 1, 1996
Nonatherosclerotic causes of coronary artery narrowing--Part IB F Waller, E T Fry, J B Hermiller, et al.Clinical Cardiology|July 1, 1996
Nonatherosclerotic causes of coronary artery narrowing--Part IIB F Waller, E T Fry, J B Hermiller, et al.Clinical Cardiology|August 1, 1996
Nonatherosclerotic causes of coronary artery narrowing--Part IIIB F Waller, E T Fry, J B Hermiller, et al.The Journal of Biological Chemistry|June 25, 1989
Characterization of interaction of active-site serine mutants of tissue-type plasminogen activator with plasminogen activator inhibitor-1J C Monge, C L Lucore, E T Fry, et al.Pageof 2